Related Experiment Videos
Basal cell carcinoma with hyaline inclusions
A A Sahin1, J Y Ro, D J Grignon
1Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Insights
This study describes an unusual basal cell carcinoma (BCC) in a 67-year-old woman, featuring unique cytoplasmic inclusions. These inclusions, identified as filament aggregates, present diagnostic challenges for pathologists.
Area of Science:
- Dermatopathology
- Surgical Pathology
- Oncology
Background:
- Basal cell carcinoma (BCC) is the most common type of skin cancer.
- BCC typically presents with characteristic histopathological features.
- Unusual variants of BCC can pose diagnostic challenges.
Observation:
- A 67-year-old female patient presented with a basal cell carcinoma on the forehead.
- The BCC exhibited numerous hyaline cytoplasmic inclusions within the tumor cells.
- These inclusions were investigated using electron microscopy and immunohistochemistry.
Findings:
- Electron microscopy revealed the inclusions to be aggregates of cytoplasmic filaments.
- Immunohistochemical analysis showed reactivity for keratin, vimentin, and smooth-muscle myosin within these inclusions.
- The presence of these specific proteins suggests a complex cellular origin or differentiation within the tumor.
Implications:
- This unusual presentation of basal cell carcinoma requires awareness among pathologists.
- Recognition of these hyaline cytoplasmic inclusions is crucial to avoid misdiagnosis.
- Understanding the composition of these inclusions may offer insights into BCC pathogenesis.
Abstract:
A 67-year-old woman had a basal cell carcinoma of the forehead containing numerous hyaline cytoplasmic inclusions. Electron microscopic studies revealed that these inclusions were aggregates of cytoplasmic filaments. Immunohistochemical studies demonstrated reactivity for keratin, vimentin, and smooth-muscle myosin in these structures. Because of potential diagnostic difficulties, the pathologist should be aware of this unusual form of basal cell carcinoma.